The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial
Open accessAbstract
IMPORTANCE: More than 80% of patients with heart failure with preserved ejection fraction (HFPEF), the most common form of heart failure among older persons, are overweight or obese. Exercise intolerance is the primary symptom of chronic HFPEF and a major determinant of reduced quality of life (QOL). OBJECTIVE: To determine whether caloric restriction (diet) or aerobic exercise training (exercise) improves exercise capacity and QOL in obese older patients with HFPEF. DESIGN, SETTING, AND PARTICIPANTS: Randomized, attention-controlled, 2 × 2 factorial trial conducted from February 2009 through November 2014 in an urban academic medical center. Of 577 initially screened participants, 100 older obese participants (mean [SD]: age, 67 years [5]; body mass index, 39.3 [5.6]) with chronic, stable HFPEF were enrolled (366 excluded by inclusion and exclusion criteria, 31 for other reasons, and 80 declined participation). INTERVENTIONS: Twenty weeks of diet, exercise, or both; attention control consisted of telephone calls every 2 weeks. MAIN OUTCOMES AND MEASURES: Exercise capacity measured as peak oxygen consumption (V̇O2, mL/kg/min; co-primary outcome) and QOL measured by the Minnesota Living with Heart Failure (MLHF) Questionnaire (score range: 0-105, higher scores indicate worse heart failure-related QOL; co-primary outcome). RESULTS: Of the 100 enrolled participants, 26 participants were randomized to exercise; 24 to diet; 25 to exercise + diet; 25 to control. Of these, 92 participants completed the trial. Exercise attendance was 84% (SD, 14%) and diet adherence was 99% (SD, 1%). By main effects analysis, peak V̇O2 was increased significantly by both interventions: exercise, 1.2 mL/kg body mass/min (95% CI, 0.7 to 1.7), P < .001; diet, 1.3 mL/kg body mass/min (95% CI, 0.8 to 1.8), P < .001. The combination of exercise + diet was additive (complementary) for peak V̇O2 (joint effect, 2.5 mL/kg/min). There was no statistically significant change in MLHF total score with exercise and with diet (main effect: exercise, -1 unit [95% CI, -8 to 5], P = .70; diet, -6 units [95% CI, -12 to 1], P = .08). The change in peak V̇O2 was positively correlated with the change in percent lean body mass (r = 0.32; P = .003) and the change in thigh muscle:intermuscular fat ratio (r = 0.27; P = .02). There were no study-related serious adverse events. Body weight decreased by 7% (7 kg [SD, 1]) in the diet group, 3% (4 kg [SD, 1]) in the exercise group, 10% (11 kg [SD, 1] in the exercise + diet group, and 1% (1 kg [SD, 1]) in the control group. CONCLUSIONS AND RELEVANCE: Among obese older patients with clinically stable HFPEF, caloric restriction or aerobic exercise training increased peak V̇O2, and the effects may be additive. Neither intervention had a significant effect on quality of life as measured by the MLHF Questionnaire. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00959660.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The study concluded that secondary outcomes (improved metabolic measures) could be generalized to the senior population (age ≥ 65 years), with evidence that weight loss intervention for older adults is effective in improving health outcomes [9,10].”
From Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease (2016) · cites this paper as [10]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A randomized trial of caloric restriction in patients with heart failure with preserved ejection fraction and obesity showed reductions in symptoms and improvements in exercise function and quality of life. 30”
From Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity (2023) · cites this paper as [30]
The cited source says what the claim attributes to it.
In the citing paper
“previous data suggesting that health status and exercise function improve with lifestyle modification-mediated weight loss in patients with heart failure with preserved ejection fraction and obesity, 30”
From Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity (2023) · cites this paper as [30]
The cited source says what the claim attributes to it.
In the citing paper
“Evidence in the past several years shows relatively rapid and sizeable improvements in major heart failure symptoms with drug-induced and lifestyle-induced weight loss among people with heart failure with preserved ejection fraction.110,111”
From Definition and diagnostic criteria of clinical obesity (2025) · cites this paper as [111]
The cited source says what the claim attributes to it.
In the citing paper
“In ten trials, a weight-reducing diet alone resulted in the desired weight loss, which consisted of fat mass as well as lean mass (290)(291)(292)(294)(295)(296)(297)(298)(299).”
From ESPEN practical guideline: Clinical nutrition and hydration in geriatrics (2022) · cites this paper as [298]
In the citing paper
“Several studies reported that (modest) weight loss caused by lifestyle interventions in obesity-related HFpEF patients improved exercise capacity but had no effect on cardiac structure or function.”
From The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF (2023) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,209
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Rich, M. W., Beckham, V., Wittenberg, C., Leven, C. L., Freedland, K. E., & Carney, R. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511023331806 · Cited by 2,327
Bariatric Surgery and Long-term Cardiovascular Events
Sjöström, L., Peltonen, M., Jacobson, P., Sjöström, C. D., Karason, K., Wedel, H., Ahlin, S., Anveden, Å., Bengtsson, C., Bergmark, G., et al. (2012) · JAMA · doi:10.1001/jama.2011.1914 · Cited by 1,656
Redfield, M. M., Chen, H. H., Borlaug, B. A., Semigran, M. J., Lee, K. L., Lewis, G. D., LeWinter, M. M., Rouleau, J. L., Bull, D. A., Mann, D. L., et al. (2013) · JAMA · doi:10.1001/jama.2013.2024 · Cited by 1,164
Weight loss, exercise, or both and physical function in obese older adults
Villareal, D. T., Chode, S., Parimi, N., Sinacore, D. R., Hilton, T., Armamento-Villareal, R., Napoli, N., Qualls, C., & Shah, K. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008234 · Cited by 1,096
Rector, T. S., & Cohn, J. N. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90986-6 · Cited by 1,020
Kitzman, D. W. (2002) · JAMA · doi:10.1001/jama.288.17.2144 · Cited by 883
Self-citation
Cited by
Sorted by citations
Items 901–921 of 921
Stoichescu-Hogea, G., Craciun, M.-L., Pah, A.-M., Avram, A. C., Rada, M., Otiman, G., Jupaneant, C., Ples, C., Mahmoud, A., & Dragan, S. R. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15187096
“…adjudicated obesity-related HFpEF populations shows that exercise, caloric restriction, semaglutide, and tirzepatide can improve selected clinical outcomes [20–24], but these trials neither validate HFpEF in the present cohort nor convert a cross-sectional BMI association into a treatment effect.”
Jones, T. L., Rawstorn, J. C., Edbrooke, L., Hayes, S. C., Maddison, R., Denehy, L., Nightingale, S., Bell, R., Halligan, I., Ismail, H., et al. (2026) · JMIR Cancer · doi:10.2196/101224
Myopenia in HFpEF: Impaired Muscle Quality Beyond the Heart
Pocai, A. (2026) · JCSM Communications · doi:10.1002/rco2.70048
Almeida-Alvarado, M. P., Solís, D. A. C., Mayorga, O. R. L., & Ávila, J. D. B. (2026) · Atlas Research Journal · doi:10.65305/arj.v4n1.2026.84
Khan, M. D., haq, M. S. U., Shaukat, M. I., Khan, M. A., shahzad, S., shahzad, S., Jamil, M., & farooq, F. (2026) · Cardiology in the Young · doi:10.1017/s1047951126124317
Li, Q., Yang, T., Jin, G., & Zhou, Y. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1930278
“The findings reinforce the heterogeneity of HFpEF and the importance of phenotype-specific interpretation (4 – 7, 47 – 50).”
Evangelista, L. S., Meraz, R., Angosta, A. D., Nguyen, A. P.-U., Wierenga, K. L., Kawi, J., Hamilton, M. A., & Fonarow, G. C. (2026) · Nutrients · doi:10.3390/nu18193238
“…in established HF remains much more limited, as shown in the randomized trial by Kitzman et al., in which caloric restriction in older adults with obesity and HFpEF reduced weight and improved peak oxygen consumption but was also associated with loss of lean body mass and thigh muscle area [15].”
Epelde, F. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1956165
“Exercise training and caloric restriction have improved exercise capacity and quality of life in obese older patients with HFpEF (57), and a contemporary meta-analysis supports exercise training as an effective component of care (58).”
Diretriz Brasileira de Insuficiência Cardíaca – 2026
Simões, M. V., Moura, L. Z., Martins, S. M., Mourilhe‐Rocha, R., Danzmann, L. C., Neto, J. A. D. F., Marcondes‐Braga, F. G., de Oliveira, M. T., de Albuquerque, D. C., Freitas, A. F., et al. (2026) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20260830
Prokopidis, K., Joshi, A. S., Gam, S., Norman, K., Müller‐Werdan, U., Doehner, W., & Langer, H. T. (2026) · Current Heart Failure Reports · doi:10.1007/s11897-026-00780-x
Qi, Z., Xu, T., Yang, C., & Tan, L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1976969
“In obese older patients with HFpEF, caloric restriction and aerobic exercise training improved peak oxygen consumption and quality of life, supporting lifestyle intervention as a clinically relevant background strategy even when EAT was not the primary endpoint (69).”
Ostrominski, J. W., Claggett, B. L., Jerosch‐Herold, M., Raja, A. A., Day, S. M., Russell, M. W. W., Zahka, K. G., Pereira, A. C., Colan, S. D., Murphy, A. M., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.050131
Wang, J., Liu, R., Zhang, X., Qi, G., Xu, Q., & Jia, F. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103412
Eisa, N., & Khoury, M. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag284
Cline, L. (2026) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000001370
Tavakoli, K., Ansari, A., Alaei, E., Jahanfard, R., Mansouri, E. S., Ganjalikhani, M., Selk-Ghaffari, M., Shahi, M. H. P., & Memari, A. H. (2026) · Journal of Cardiology · doi:10.1016/j.jjcc.2026.10.004
An α1D-adrenergic receptor vaccine protects against HFpEF in mice
Wu, J., Shi, D., Wang, Y., Ma, Q., Chen, H., Huang, J., Ma, W., Lama, E., Liu, C., Gao, R., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117604
Hwach, A. A., Dasdemir, A., Ahrens, D., Roeper, M., Tanev, I., Hansen, M., Janashia, M., Rauwolf, T., Popescu, M. R., Pareek, M., et al. (2026) · Nutrients · doi:10.3390/nu18213483
Bartlett, M. F., Ren, J., Sarma, S., MacNamara, J. P., Brazile, T. L., Wakeham, D. J., Hearon, C. M., Lutz, K. C., Fadel, P. J., Haykowsky, M. J., et al. (2026) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00683.2026
Self-citationFernández‐Cisnal, A., Lorenzo, M., Palau, P., & Núñez, J. E. (2026) · Medicina Clínica · doi:10.1016/j.medcli.2026.107617
Dev, R., Zhang, J. Y., Lin, K. T., & Orach, J. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15218430
Metadata
- Authors
- Kitzman, D. W., Brubaker, P., Morgan, T., Haykowsky, M., Hundley, G., Kraus, W. E., Eggebeen, J., & Nicklas, B. J.
- Affiliations
- Wake Forest University Health Sciences (US)
- Wake Forest University (US)
- The University of Texas at Arlington (US)
- Cardiology Section, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina
- Duke University (US)
- Emory University (US)
- Corresponding author
- Kitzman, Dalane W.
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-01-05
- Volume
- 315
- Issue
- 1
- Pages
- 36
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC4787295
- OpenAlex
- W2231944090
- Cited by
- 921
- References
- 44
- Citations by year
- 2026: 94 · 2025: 117 · 2024: 121 · 2023: 89 · 2022: 92 · 2021: 92 · 2020: 90 · 2019: 69 · 2018: 60 · 2017: 66 · 2016: 29
- FWCI
- 153.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of Texas at Arlington
- National Institutes of Health (UL1TR001420, R01AG18915)
- Wake Forest School of Medicine (P30AG021332)
- National Institute on Aging (R01AG020583, R01 AG18915, R01AG018915, R37AG018915, P30AG021332)
- National Heart, Lung, and Blood Institute (R01HL093713)
- National Center for Research Resources (M01RR007122)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- heart failure with preserved ejection fraction, obesity, older adults, caloric restriction, aerobic exercise training, peak oxygen uptake, exercise capacity, quality of life, diet and exercise combination, exercise intolerance, heart failure
- MeSH terms
- Aged, Body Composition, Combined Modality Therapy, Female, Heart Failure, Humans, Male, Middle Aged, Obesity, Oxygen Consumption, Patient Compliance, Quality of Life, Surveys and Questionnaires, Stroke Volume, Weight Loss, Exercise, Body Mass Index, Single-Blind Method, Exercise Tolerance, Caloric Restriction, Physical Conditioning, Human
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review